絞り込み

16554

広告

Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.

著者 Mazard T , Boonsirikamchai P , Overman MJ , Asran MA , Choi H , Herron D , Eng C , Maru DM , Ychou M , Vauthey JN , Loyer EM , Kopetz S
Gut.2017 Oct 30 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (43view , 0users)

Full Text Sources

Medical

The purpose was to validate the prognostic value of an early optimal morphological response on CT in patients treated with bevacizumab-containing chemotherapy for unresectable colorectal cancer liver metastases (CLM). It also evaluated the prognostic value of size-based criteria and the association of optimal morphological response with the receipt of bevacizumab.
PMID: 29084828 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード